Department of Biochemistry and Molecular Biology I, University of Granada, Granada 18071, Spain.
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain.
Hum Mol Genet. 2021 Nov 16;30(23):2263-2271. doi: 10.1093/hmg/ddab187.
SWitch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complexes are key epigenetic regulators that are recurrently mutated in cancer. Most studies of these complexes are focused on their role in regulating protein-coding genes. However, here, we show that SWI/SNF complexes control the expression of microRNAs. We used a SMARCA4-deficient model of lung adenocarcinoma (LUAD) to track changes in the miRNome upon SMARCA4 restoration. We found that SMARCA4-SWI/SNF complexes induced significant changes in the expression of cancer-related microRNAs. The most significantly dysregulated microRNA was miR-222, whose expression was promoted by SMARCA4-SWI/SNF complexes, but not by SMARCA2-SWI/SNF complexes via their direct binding to a miR-222 enhancer region. Importantly, miR-222 expression decreased cell viability, phenocopying the tumor suppressor role of SMARCA4-SWI/SNF complexes in LUAD. Finally, we showed that the miR-222 enhancer region resides in a topologically associating domain that does not contain any cancer-related protein-coding genes, suggesting that miR-222 may be involved in exerting the tumor suppressor role of SMARCA4. Overall, this study highlights the relevant role of the SWI/SNF complex in regulating the non-coding genome, opening new insights into the pathogenesis of LUAD.
SWI/SNF 染色质重塑复合物是关键的表观遗传调节剂,在癌症中经常发生突变。大多数关于这些复合物的研究都集中在它们对调节蛋白编码基因的作用上。然而,在这里,我们表明 SWI/SNF 复合物控制 microRNA 的表达。我们使用 SMARCA4 缺陷型肺腺癌 (LUAD) 模型来跟踪 SMARCA4 恢复后 miRNome 的变化。我们发现 SMARCA4-SWI/SNF 复合物诱导了与癌症相关的 microRNA 表达的显著变化。最显著失调的 microRNA 是 miR-222,其表达受 SMARCA4-SWI/SNF 复合物促进,但不受 SMARCA2-SWI/SNF 复合物通过其直接结合到 miR-222 增强子区域的影响。重要的是,miR-222 的表达降低了细胞活力,模拟了 SMARCA4-SWI/SNF 复合物在 LUAD 中的肿瘤抑制作用。最后,我们表明 miR-222 增强子区域位于拓扑关联域内,该区域不包含任何与癌症相关的蛋白编码基因,表明 miR-222 可能参与发挥 SMARCA4 的肿瘤抑制作用。总的来说,这项研究强调了 SWI/SNF 复合物在调节非编码基因组中的相关作用,为 LUAD 的发病机制提供了新的见解。